Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Complete recall history across all FDA and CPSC categories, 105 total recalls

Lowlite Investments, Inc. D/B/A Olympia Pharmacy appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.

Drug Recalls (105)

FDA drug safety enforcement actions by Lowlite Investments, Inc. D/B/A Olympia Pharmacy. Showing most recent 50.

Date Product Reason Class
May 29, 2013 Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Vitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 2... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Atipamezole 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Ketoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmac... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 PEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olymp... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympi... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlan... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Gentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Sodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Disodium EDTA Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Miconazole 3% Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Betamethasone Phosphate/Acetate 6 mg/ml Injection, compounded by Olympia Phar... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Vitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Betamethasone Sodium Phosphate 12 mg/ml Injection, compounded by Olympia Phar... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Alprostadil 2000 mcg/ml, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml Injection, compounded by Olymp... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Dexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharm... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 BNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Aminophylline 2.5% Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounde... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Aminocaproic Acid 0.5mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, com... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Or... Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Quadmix, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Tripelennamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II
May 29, 2013 Medetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... Class II

View all 105 drug recalls →

Frequently Asked Questions

A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.

Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.

The FDA classifies recalls into three categories. Class I is the most serious, there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious, the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.

Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.

Explore More Recalls

Search recalls by category, state, reason, or firm across all our databases.